Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
Bordetella pertussis toxin
Cat No.
CEI-1601
Description
This Bordetella pertussis toxin has been developed in response to the increasing pressure on the IVD industry to supply highly specific, cost-effective antibody capture systems, which are needed for monitoring vaccination programmes. FHA, a major cause of false results, is removed from the preparation by two rounds of chromatography. Bordetella pertussis is grown in batch culture, then the supernatant harvested and concentrated. Several rounds of chromatography are used to purify the native toxin to a very high level and with minimal lot-to-lot variation. CHO cell assays demonstrate a clustering concentration of between 0.01 and 0.005 ng/ml. The toxin is offered in lyophilized format, but is also produced in glycerol or liquid formulation depending on customer desire.
Source
E. coli
Form
Lyophilised
Purity
>98% pure by SDS-PAGE
Concentration
0.25 mg/ml
Storage
2-8°C
Synonyms
pertussis toxin
Reconstitution
Reconstitution of one vial with 2 ml distilled water will give a solution containing 50ug of pertussis toxin, 0.05M sodium phosphate buffer at pH7.2 and 0.5M sodium chloride.
Download
Download Datasheet